Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not

professional advice and should not be used in lieu of obtaining advice from a qualified health

care provider. And now on to the show. Welcome to Helix Tech episode 112. I'm your co-host,

Dr. Cain. And I'm Dr. Patel. The title of our today's episode is Fishing for Benefits,

the Evidence for Cardiovascular Risk Reduction for the Fish Oils.

Dr. Patel, why are we talking about fish oils?

My impression has always been that maybe fish oils have kind of fallen out of favor

because of a host of negative data.

What is new about

fish oils that really prompted today's episode?

So there is a new formulation of fish oil that's prescription-only product. And instead of

containing the both components of the omega-3 fatty acid, which is the DHA plus EPA, we're going to elaborate those names in just a little bit.

This new one contains only the EPA kind of omega-3 fatty acid.

And it has been put through a clinical trial with clinical outcomes.

And so without spilling the beans right here, there's some good clinical outcomes associated with that.

There has started up some discussion between cardiology groups and primary care group.

And so that's, we are hoping to discuss. Plus, some of the updated guidelines we have for the

cholesterol management from AHA, ACC, the 2013 or the 2018, do not include this

trial results yet because this trial was published actually earlier to mid-yet last year

only.

...